NeuroCentrix is a private neuroscience facility dedicated to evidence-based assessment, treatment and research of memory and mood disorders.
Our memory and mood clinics provide evidence-based assessment and treatment plans for Alzheimer’s Disease and depression.
Our TMS (Transcranial Magnetic Stimulation) therapy offers a non-invasive treatment for major depressive disorders.
We conduct Phase II to Phase IV pharmaceutical sponsored trials, investigator-initiated research and collaborative group studies in neurological disorders.
Repetitive Transcranial Magnetic Stimulation (rTMS) is a recognised treatment for depression and other neurological conditions.
Clinical studies have demonstrated the effectiveness of TMS in the treatment of depression, particularly in patients who have not responded well to anti-depressant medication.
TMS is a non-invasive treatment delivered by an external magnetic coil placed above the head. The coil sends repetitive electromagnetic pulses to stimulate neuron activity in specific surface areas of the brain that regulate mood.
TMS is an approved treatment for depression in Australia, Canada, the United States and the United Kingdom.
NeuroCentrix does not provide an emergency or an immediate response service. If you are feeling suicidal or in a crisis, please seek help immediately.
If you are in Australia please call:
Please note that, for your own safety, if you tell us that you intend to commit suicide we have an obligation to inform the police.
Emergency assessment for mental health problems is available at all major hospitals 24 hours a day. This can be accessed though the local emergency department directly or by ringing the emergency department triage nurse.
Other helpful sources of information about anxiety and depression include:
In the current climate of containing the COVID-19 virus, NeuroCentrix is working proactively to provide a safe environment for all visitors and staff.
The key points of our protocol are:
All of our staff are happy to discuss our COVID-19 procedures with you in more detail.
NeuroCentrix provides access to clinical trials and potential new treatments for individuals with Alzheimer’s disease and Major Depression Disorder
© 2020 NeuroCentrix | Privacy Statement | Terms & Condtions
NeuroCentrix invites you to learn more about a Clinical Research Trial involving the use of a new investigational medication.
If you suffer from treatment resistant depression, you may like to consider participating in a Clinical Research Study of a new oral anti-depressant medication.